These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8780205)

  • 1. Kininogen changes in human plasma following a test meal or insulin administration.
    Rothschild AM; Boden G; Colman RW
    Am J Physiol; 1996 Mar; 270(3 Pt 2):H1071-7. PubMed ID: 8780205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kininogen changes in human plasma following a test meal or insulin administration.
    Rothschild AM; Boden G; Colman RW
    Immunopharmacology; 1996 Jun; 33(1-3):354-8. PubMed ID: 8856185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kininogen and prekallikrein increases in the blood of streptozotocin-diabetic rats are normalized by insulin in vivo and in vitro.
    Rothschild AM; Melo VL; Reis ML; Foss MC; Gallo L
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):217-20. PubMed ID: 10494893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat.
    Rothschild AM; Gomes EL; Fortunato IC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):483-8. PubMed ID: 9826071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
    Zini JM; Schmaier AH; Cines DB
    Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the presence of a kininogen-like species in a case of total deficiency of low and high molecular weight kininogens.
    Veloso D
    Braz J Med Biol Res; 1998 Jul; 31(7):901-10. PubMed ID: 9698753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
    Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
    Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA).
    Scott CF; Shull B; Müller-Esterl W; Colman RW
    Thromb Haemost; 1997 Jan; 77(1):109-18. PubMed ID: 9031459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.
    Ben Nasr A; Herwald H; Sjöbring U; Renné T; Müller-Esterl W; Björck L
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):657-60. PubMed ID: 9307013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells.
    Hasan AA; Zhang J; Samuel M; Schmaier AH
    Thromb Haemost; 1995 Oct; 74(4):1088-95. PubMed ID: 8560418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK).
    Mannhalter C; Lang H
    Thromb Haemost; 1988 Dec; 60(3):447-52. PubMed ID: 3238647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of the kininogens.
    Schmaier AH; Wahl R; Fisher SJ; Brenner D
    Thromb Res; 1998 Dec; 92(6):293-7. PubMed ID: 9870897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
    Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
    Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
    DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
    Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on kininogen bioassay in human and rat plasma by means of trypsin and guinea pig ileum.
    Karp M; Pyykönen ML; Ylitalo P
    Pol J Pharmacol Pharm; 1986; 38(2):185-91. PubMed ID: 3748890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis.
    Cugno M; Salerno F; Mandelli M; Lorenzano E; Paonessa R; Agostoni A
    Thromb Res; 1995 May; 78(4):277-82. PubMed ID: 7631308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.